Literature DB >> 11737987

Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.

P C Ho1, D J Saville, S Wanwimolruk.   

Abstract

PURPOSE: To evaluate the inhibition of CYP3A4 activity in human liver microsomes by flavonoids, furanocoumarins and related compounds and investigate possibly more important and potential inhibitors of CYP3A4 in grapefruit juice.
METHODS: The effects of various flavonoids and furanocoumarin derivatives on CYP3A4 activity in two human liver microsomal samples was determined using quinine as a substrate. All flavonoids and furanocoumarin derivatives were dissolved in DMSO. In all cases, inhibition activities were compared with activities in control incubations containing 0.2% (v/v) DMSO.
RESULTS: The results showed that the inhibition of quinine 3-hydroxylation (CYP3A4 activity) by bergapten (67%), and quercetin (55%) was greater than naringenin (39%) and naringin (6%), at the same inhibitor concentration of 100 M. The results also demonstrated that the furan ring in the furanocoumarins enhanced the inhibitory effect on CYP3A4 activity. Flavonoids with more phenolic hydroxyl (-OH) groups produced stronger inhibition than those with less hydroxyl groups. Of all the chemicals studied, bergapten (5-methoxypsoralen) with the lowest IC50 value (19-36 microM) was the most potent CYP3A4 inhibitor.
CONCLUSIONS: These results suggest that more than one component present in grapefruit juice may contribute to the inhibitory effect on CYP3A4. Bergapten appears to be a potent inhibitor of CYP3A4, and may therefore be primarily responsible for the effect of grapefruit juice on CYP3A4 activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737987

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  31 in total

1.  Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms.

Authors:  Wenjie Jessie Lu; Valentina Ferlito; Cong Xu; David Alastair Flockhart; Salvatore Caccamese
Journal:  Chirality       Date:  2011-09-22       Impact factor: 2.437

2.  Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity.

Authors:  Gareth E Lim; Timao Li; Harpal S Buttar
Journal:  Exp Clin Cardiol       Date:  2003

3.  Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout mice.

Authors:  Nicholas Seneca; Sami S Zoghbi; H Umesha Shetty; Edward Tuan; Pavitra Kannan; Andrew Taku; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2010-04       Impact factor: 2.408

4.  Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation.

Authors:  Eberhard P Scholz; Edgar Zitron; Claudia Kiesecker; Sonja Lück; Dierk Thomas; Sven Kathöfer; Volker A W Kreye; Hugo A Katus; Johann Kiehn; Wolfgang Schoels; Christoph A Karle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-09       Impact factor: 3.000

5.  Inhibition of CYP6B1-mediated detoxification of xanthotoxin by plant allelochemicals in the black swallowtail (Papilio polyxenes).

Authors:  Zhimou Wen; May R Berenbaum; Mary A Schuler
Journal:  J Chem Ecol       Date:  2006-03-30       Impact factor: 2.626

6.  Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening.

Authors:  Thangavel Mahalingam Vijayakumar; Ramasamy Mohan Kumar; Aruna Agrawal; Govind Prasad Dubey; Kaliappan Ilango
Journal:  J Food Sci Technol       Date:  2014-07-22       Impact factor: 2.701

7.  Controlled inactivation of recombinant viruses with vitamin B2.

Authors:  Shellie M Callahan; Piyanuch Wonganan; Linda J Obenauer-Kutner; Suganto Sutjipto; Joseph D Dekker; Maria A Croyle
Journal:  J Virol Methods       Date:  2007-12-21       Impact factor: 2.014

8.  Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats.

Authors:  K Kishore Kumar; Leena Priyanka; K Gnananath; P Ravindra Babu; S Sujatha
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-05-29       Impact factor: 2.441

Review 9.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).

Authors:  Sompon Wanwimolruk; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-04-02       Impact factor: 4.068

10.  Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study.

Authors:  T K Motawi; Z A Teleb; N A El-Boghdady; S A Ibrahim
Journal:  J Physiol Biochem       Date:  2013-11-22       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.